A detailed history of Hantz Financial Services, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 254 shares of INCY stock, worth $21,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares
254
Previous 65 290.77%
Holding current value
$21,686
Previous $4,000 325.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025

BUY
$55.17 - $71.22 $10,427 - $13,460
189 Added 290.77%
254 $17,000
Q1 2025

May 12, 2025

BUY
$60.0 - $75.26 $3,900 - $4,891
65 New
65 $4,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $19B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.